Due to the fact that FOXM1 is a transcription factor present at high levels in many breast cancers and associated with poor patient outcomes, we examined in this study the effects of FOXM1 inhibition on breast cancer cells and the changes that occur in long-term treated cells that acquire resistance to these inhibitors. Here, FOXM1 is linked to breast cancer.